Professor of Psychiatry at University of Pittsburgh School of Medicine
Psychiatry
Dr. Roger F. Haskett, MD
|
|
Give Review
Dr. Roger F. Haskett practices Psychiatry. He received 1 awards: "Top MD". Roger F. Haskett is a published doctor. He has 97 papers published. The most current publication "Fluoxetine versus placebo in depressed alcoholic cocaine abusers."
Publications
- Guidelines for preventing common medical complications of catatonia: case report and literature review.
- Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.
- Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy.
- Citalopram improves metabolic risk factors among high hostile adults: Results of a placebo-controlled intervention.
- Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and Schizophrenia.
- Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
- Best practices: an intervention to promote evidence-based prescribing at a large psychiatric hospital.
- Citalopram intervention for hostility: results of a randomized clinical trial.
- Screening for depression in the postpartum period: a comparison of three instruments.
- Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
- Predictors of remission after electroconvulsive therapy in unipolar Major depression.
- Clinical outcome of ECT in patients with major depression and comorbid borderline personality Disorder.
- Addressing depression in obstetrics/gynecology practice.
- A randomized comparison of high-charge right unilateral electroconvulsive therapy and bilateral electroconvulsive therapy in older depressed patients who failed to res...
- Full and Abbreviated Courses of Maintenance Electroconvulsive Therapy.
- Protective Effects of Intramuscular Glycopyrrolate on Cardiac Conduction During ECT.
- Relative Efficacy of Unilateral and Bilateral Electroconvulsive Therapy in Melancholia.
- Neuroendocrine effects of L-tryptophan and dexamethasone.
- Dexamethasone suppression test status and severity of depression.
- Major depressive Disorder and panic Disorder. Effects of comorbidity on treatment outcome with antidepressant medications.
- Plasma postdexamethasone cortisol levels in schizoaffective Disorder.
- Predictors of response to electroconvulsive therapy in major depressive Disorder.
- Monitoring of antidepressant response to ECT with polysomnographic recordings and the dexamethasone suppression test.
- The dexamethasone suppression test in inpatients with panic Disorder or agoraphobia with panic attacks.
- Multiple Depressive episodes and plasma postdexamethasone cortisol levels.
- Premenstrual dysphoric Disorder: evaluation, pathophysiology and treatment.
- Clinical correlates of sleep onset REM periods in depression.
- Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
- A psychoendocrine study of premenstrual tension syndrome. A model for endogenous depression?
- Lorazepam withdrawal and seizures.
- Morphine inhibits cortisol and stimulates prolactin secretion in man.
- Circadian hormone secretory profiles in women with severe premenstrual tension syndrome.
- Plasma prolactin and severe premenstrual tension.
- Premenstrual tension syndrome: diagnostic criteria and selection of research subjects.
- Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression.
- Neuroendocrine Disorders and psychopathology.
- Relevance of neuroendocrine strategies for electroconvulsive therapy research.
- Factors affecting outcome after successful electroconvulsive therapy.
- Severe premenstrual tension: delineation of the syndrome.
- Treatment of premenstrual tension with lithium carbonate. A pilot study.
- Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales.
- Postnatal gonadal steroid effects on human behavior.
- Neuroendocrine evaluation of depression in borderline patients.
- Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
- Neuroendocrine diagnostic criteria for depression [proceedings].
- A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
- Evidence against changes in corticotroph CRF receptors in depressed patients.
- Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.
- Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.
- Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls.
- Dissociation between pituitary and adrenal suppression to dexamethasone in depression.
- Resistance to antidepressant medications and short-term clinical response to ECT.
- Fluoxetine versus phenelzine in atypical depression.
- Low use of neuroleptic Drugs in the treatment of psychotic major depression.
- Fluoxetine versus placebo in depressed Alcoholic cocaine abusers.
- Fluoxetine versus placebo for the marijuana use of depressed Alcoholics.
- Acute efficacy of ECT in the treatment of Major depression in the old-old.
- Psychosocial functioning in women with premenstrual dysphoric Disorder before and after treatment with sertraline or placebo.
- Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors.
- Fluoxetine versus placebo in depressed Alcoholics: a 1-year follow-up study.
- Use of electroconvulsive therapy in a state hospital: a 10-year review.
- Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
- Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
- Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.
- The premenstrual tension syndrome rating scales: an updated version.
- Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
- Neurotransmitter studies of neuroendocrine pathology in depression.
- Age effects in serial hypothalamic-pituitary-adrenal monitoring.
- Natural killer cell activity in Depressive illness: preliminary report.
- Serial dexamethasone suppression tests in simultaneous panic and depressive Disorders.
- Cortisol escape from morphine suppression.
- Diagnosing premenstrual tension syndrome.
- Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
- Prolactin response to morphine in depression.
- Escape from dexamethasone suppression: possible role of an impaired inhibitory opioid mechanism.
- Urinary free cortisol levels among depressed men and women: differential relationships to age and symptom severity?
- EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive Disorder.
- A longitudinal evaluation of dexamethasone pharmacokinetics in depressed patients and normal controls.
- Seasonality in atypical depression.
- Loss of glucocorticoid fast feedback in depression.
- Menstrual cycle effects on the dexamethasone suppression test in Major depression.
- Heterogeneity in the beta-endorphin immunoreactivity response to electroconvulsive therapy.
- Effect of hyperventilation on seizure length during electroconvulsive therapy.
- Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies.
- Electroconvulsive therapy in delusional and non-delusional depressive Disorder.
- Comorbidity of panic Disorder and major depressive Disorder: effects on platelet alpha 2 adrenergic receptors.
- A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant Drugs.
- A preliminary magnetic resonance imaging study of ECT-treated depressed patients.
- Multiplicity of Depressive episodes: phenomenological and neuroendocrine correlates.
- Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
- Comparison of early and delayed inpatient dexamethasone suppression tests.
- Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
- Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy.
- Hormone response to repeated electroconvulsive therapy: effects of naloxone.
- Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
- Prolactin response to TRH in depression.
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcohol-Induced Mental Disorders
- Alcoholism (Alcohol Dependence)
- Antisocial Personality Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Community Blue PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
Awards
- Top MD
Education
-
University of Michigan Hospitals and Health Centers -
University of Melbourne Faculty of Medicine
Hospital
-
UPMC Presbyterian Shadyside
Helpful Reviews
Similar Doctors
|
|
Dr. Leonid S. Krimer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Mannheimer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon G. Rechter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo J. Bastiaens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Klunk, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Todd M. Barr, MD |
|
|
Dr. Gregory L. Cherpes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin K. Smith, MD |